MedTrace Logo

The Study is to Investigate D-2570 in Participants With Different Levels of Kidney Function.

NCT07715175 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-07-23

No results posted yet for this study

Summary

This study is divided two parts into: Part A and Part B. Part A will recruit 24 research participants, and Part B will recruit 16 research participants.

Conditions

  • Renal Impairment

Interventions

DRUG

D-2570

receive a single dose of D-2570

Sponsors & Collaborators

  • InventisBio Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Huan Zhou, Doctor · The First Affiliated Hospital of Anhui Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-09
Primary Completion
2026-11-21
Completion
2026-11-21

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07715175 on ClinicalTrials.gov